Selection of Naturally Occurring Extended-Spectrum TEM β-Lactamase Variants by Fluctuating β-Lactam Pressure

ABSTRACT Despite the large number of in vitro mutations that increase resistance to extended-spectrum cephalosporins in TEM-type β-lactamases, only a small number occur in naturally occurring enzymes. In nature, and particularly in the hospital, bacteria that contain β-lactamases encounter simultaneous or consecutive selective pressure with different β-lactam molecules. All variants obtained by submitting an Escherichia coli strain that contains ablaTEM-1 gene to fluctuating challenge with both ceftazidime and amoxicillin contained only mutations previously detected in naturally occurring β-lactamases. Nevertheless, some variants obtained by ceftazidime challenge alone contained mutations never detected in naturally occurring TEM β-lactamases, suggesting that extended-spectrum TEM variants in hospital isolates result from fluctuating selective pressure with several β-lactams rather than selection with a single antibiotic.

[1]  F. Baquero,et al.  A237T as a Modulating Mutation in Naturally Occurring Extended-Spectrum TEM-Type β-Lactamases , 1998, Antimicrobial Agents and Chemotherapy.

[2]  Wanzhi Huang,et al.  Selection and Characterization of Amino Acid Substitutions at Residues 237-240 of TEM-1 β-Lactamase with Altered Substrate Specificity for Aztreonam and Ceftazidime* , 1996, The Journal of Biological Chemistry.

[3]  F. Sanger,et al.  DNA sequencing with chain-terminating inhibitors. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[4]  F. Baquero,et al.  Characterization of a new TEM-type beta-lactamase resistant to clavulanate, sulbactam, and tazobactam in a clinical isolate of Escherichia coli , 1993, Antimicrobial Agents and Chemotherapy.

[5]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[6]  Mary Jane Ferraro,et al.  Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically : approved standard , 2000 .

[7]  J. Petrosino,et al.  Systematic mutagenesis of the active site omega loop of TEM-1 beta-lactamase , 1996, Journal of bacteriology.

[8]  T. Palzkill.  A natural polymorphism in b-lactamase is a global suppressor ( antibiotic resistance y protein evolution , 1997 .

[9]  J Péduzzi,et al.  An additional ionic bond suggested by molecular modelling of TEM-2 might induce a slight discrepancy between catalytic properties of TEM-1 and TEM-2 beta-lactamases. , 1996, FEMS microbiology letters.

[10]  J M Ghuysen,et al.  A standard numbering scheme for the class A beta-lactamases. , 1991, The Biochemical journal.

[11]  M. Larocco,et al.  Evolution of antibiotic resistance: several different amino acid substitutions in an active site loop alter the substrate profile of β‐lactamase , 1994, Molecular microbiology.

[12]  K. Bush,et al.  Classification of beta-lactamases: groups 1, 2a, 2b, and 2b' , 1989, Antimicrobial Agents and Chemotherapy.

[13]  J. Waitz.  Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically , 1990 .

[14]  A. Medeiros,et al.  Evolution and dissemination of beta-lactamases accelerated by generations of beta-lactam antibiotics. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[15]  John Maynard Smith,et al.  Natural Selection and the Concept of a Protein Space , 1970, Nature.

[16]  K. Struhl,et al.  An efficient method for generating proteins with altered enzymatic properties: application to beta-lactamase. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[17]  E. Bruck,et al.  National Committee for Clinical Laboratory Standards. , 1980, Pediatrics.

[18]  M. Larocco,et al.  Characterization of TEM-1 beta-lactamase mutants from positions 238 to 241 with increased catalytic efficiency for ceftazidime. , 1994, The Journal of biological chemistry.

[19]  G. Jacoby,et al.  A functional classification scheme for beta-lactamases and its correlation with molecular structure , 1995, Antimicrobial agents and chemotherapy.

[20]  D. Botstein,et al.  Identification of amino acid substitutions that alter the substrate specificity of TEM-1 beta-lactamase , 1992, Journal of bacteriology.

[21]  F. Baquero,et al.  Implication of Ile-69 and Thr-182 residues in kinetic characteristics of IRT-3 (TEM-32) beta-lactamase , 1996, Antimicrobial agents and chemotherapy.

[22]  Stuart A. Kauffman,et al.  ORIGINS OF ORDER , 2019, Origins of Order.

[23]  F. Baquero,et al.  Single amino acid replacements at positions altered in naturally occurring extended-spectrum TEM beta-lactamases , 1995, Antimicrobial agents and chemotherapy.